Top Markets
Coin of the day
ABVC BioPharma, Inc. ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVC
Clasificación en acciones #28871
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Precio por acción
$0.9142
Capitalización bursátil
$23.77M
Cambio (1 día)
5.55%
Cambio (1 año)
-67.92%
País
US
Comercio ABVC BioPharma, Inc. (ABVC)

Categoría

Número de acciones en circulación de ABVC BioPharma, Inc. (ABVC)
Número de acciones en circulación al August 2026: 0
Según los últimos informes financieros y el precio de las acciones de ABVC BioPharma, Inc., el número actual de acciones en circulación es 0. Al final de August 2026, la empresa tenía 0 acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de ABVC BioPharma, Inc. (ABVC) desde 2026 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
Not enough data for the provided dates.
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
253.90M -
US
62.19M -
NL
396.00M -
US
483.58M -
AU
- -
CH